CASI Pharmaceuticals Inc — Cash Flow (NASDAQ:CASI) | MetaTrader

Open full chart

Financials

Overview Relatórios Statistics Dividends

Quarterly Annual

Cash from operating activities 21.09 M19.97 M29.2 M — Cash from investing activities 31.16 M9.67 M11.24 M — Cash from financing activities 3.27 M907 K15.43 M — Free cash flow 15.48 M17.73 M28.96 M —

Notícias

What Drove CASI Pharmaceuticals' 24% Rise After Hours? - CASI Pharmaceuticals (NASDAQ:CASI)

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.63%

E.U.A. - Ações fecharam o pregão em alta e o Índice Dow Jones Industrial Average avançou 0,63%

Ações da CASI Pharmaceuticals despencam após notificação de exclusão da Nasdaq

CASI Pharmaceuticals stock plunges on Nasdaq delisting notice

Is Alkermes (ALKS) Outperforming Other Medical Stocks This Year?

Are Medical Stocks Lagging Alkermes (ALKS) This Year?

China approves CASI Pharmaceuticals’ CID-103 clinical trial for kidney rejection

Ações da CASI Pharmaceuticals disparam após Nasdaq conceder extensão de listagem

Casi Pharmaceuticals garante extensão de listagem na Nasdaq até fevereiro de 2026

CASI Pharmaceuticals stock surges after Nasdaq grants listing extension

Casi Pharmaceuticals secures Nasdaq listing extension until February 2026